Detection of human papillomavirus genotypes, herpes simplex, varicella zoster and cytomegalovirus in breast cancer patients.
Adult
Aged
Aged, 80 and over
Alphapapillomavirus
/ genetics
Breast
/ pathology
Breast Neoplasms
/ virology
Cytomegalovirus
/ genetics
DNA, Viral
/ analysis
Female
Genotype
Herpesvirus 1, Human
/ genetics
Herpesvirus 2, Human
/ genetics
Herpesvirus 3, Human
/ genetics
Humans
Middle Aged
Papillomaviridae
/ classification
Paraffin Embedding
Varicellovirus
/ classification
Breast cancer
Genotype
HPV
Herpes virus
Human papillomavirus
PCR
Journal
Virology journal
ISSN: 1743-422X
Titre abrégé: Virol J
Pays: England
ID NLM: 101231645
Informations de publication
Date de publication:
22 01 2021
22 01 2021
Historique:
received:
24
06
2020
accepted:
18
01
2021
entrez:
23
1
2021
pubmed:
24
1
2021
medline:
3
9
2021
Statut:
epublish
Résumé
The role of viruses as a cause of breast cancer (BC) has been significantly investigated in recent years. Human papillomavirus (HPV) has been detected in invasive breast carcinomas, while most studies have only focused on the detection of viral DNA, we aimed to examine the prevalence and genotypes of HPV among Iranian BC patients. We also examined the presence of herpes simplex-1 (HSV-1), herpes simplex-2 (HSV-2), varicella zoster virus (VZV), and cytomegalovirus (CMV) in these samples. We collected and analyzed 70 Formalin-Fixed Paraffin-Embedded (FFPE) blocks including 59 BC samples, and 11 benign breast lesions as control from Iranian patients using nested PCR. Real-time PCR utilized as a confirming test to nested PCR findings. Genotyping of HPV positive samples was performed, the samples were also subjected to a multiplex PCR to detect HSV-1, HSV-2, VZV, and CMV in BC. Papillomavirus DNA was present in 7 of 59 BC samples (11.8%); while none was detected in control samples. The most prevalent type was HPV18, followed by HPV 6. All HPV positive patients had high tumor grades (II/ III) with a histologic diagnosis of ductal carcinoma. The patient age range was 33 to 73 years with a median of 51 years. Most of HPV positive patients had low levels of education. HPV16 was not detected. Also, 5 of 59 BC specimens (8.47%), were positive for HSV-1. But none of the samples were positive for HSV-2, VZV, and CMV. Our results suggest a carcinogenesis role for High-risk HPV (HPV18) in breast tumors. Our findings of HSV-1 and low-risk HPV (HPV6) in BCs may propose a cancer-causing role for them. Further large-scale studies are warranted to assess the significance of our findings.
Sections du résumé
BACKGROUND
The role of viruses as a cause of breast cancer (BC) has been significantly investigated in recent years. Human papillomavirus (HPV) has been detected in invasive breast carcinomas, while most studies have only focused on the detection of viral DNA, we aimed to examine the prevalence and genotypes of HPV among Iranian BC patients. We also examined the presence of herpes simplex-1 (HSV-1), herpes simplex-2 (HSV-2), varicella zoster virus (VZV), and cytomegalovirus (CMV) in these samples.
METHODS
We collected and analyzed 70 Formalin-Fixed Paraffin-Embedded (FFPE) blocks including 59 BC samples, and 11 benign breast lesions as control from Iranian patients using nested PCR. Real-time PCR utilized as a confirming test to nested PCR findings. Genotyping of HPV positive samples was performed, the samples were also subjected to a multiplex PCR to detect HSV-1, HSV-2, VZV, and CMV in BC.
RESULTS
Papillomavirus DNA was present in 7 of 59 BC samples (11.8%); while none was detected in control samples. The most prevalent type was HPV18, followed by HPV 6. All HPV positive patients had high tumor grades (II/ III) with a histologic diagnosis of ductal carcinoma. The patient age range was 33 to 73 years with a median of 51 years. Most of HPV positive patients had low levels of education. HPV16 was not detected. Also, 5 of 59 BC specimens (8.47%), were positive for HSV-1. But none of the samples were positive for HSV-2, VZV, and CMV.
CONCLUSIONS
Our results suggest a carcinogenesis role for High-risk HPV (HPV18) in breast tumors. Our findings of HSV-1 and low-risk HPV (HPV6) in BCs may propose a cancer-causing role for them. Further large-scale studies are warranted to assess the significance of our findings.
Identifiants
pubmed: 33482849
doi: 10.1186/s12985-021-01498-z
pii: 10.1186/s12985-021-01498-z
pmc: PMC7821692
doi:
Substances chimiques
DNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
25Références
Front Oncol. 2015 Dec 16;5:277
pubmed: 26734565
Biomed Rep. 2020 Jan;12(1):30-34
pubmed: 31839947
Asia Pac Fam Med. 2008 Dec 20;7(1):6
pubmed: 19099595
Virology. 2010 May 25;401(1):70-9
pubmed: 20206957
Breast Cancer Res. 2005;7(1):R1-11
pubmed: 15642157
Sci Rep. 2015 Dec 14;5:18081
pubmed: 26658849
Breast Cancer Res Treat. 2011 Apr;126(2):515-20
pubmed: 20740311
Br J Cancer. 1992 Jun;65(6):891-4
pubmed: 1319728
Breast J. 2006 Jan-Feb;12 Suppl 1:S70-80
pubmed: 16430400
Med Dosw Mikrobiol. 2016;68(1):73-84
pubmed: 28146625
Br J Cancer. 1988 Jan;57(1):1-5
pubmed: 2831924
J Clin Virol. 2004 Dec;31(4):292-7
pubmed: 15494272
BMC Cancer. 2019 Jan 14;19(1):61
pubmed: 30642295
Discov Med. 2019 Mar;27(148):163-166
pubmed: 31095925
BMC Infect Dis. 2014 Dec 09;14:677
pubmed: 25857319
ScientificWorldJournal. 2012;2012:837191
pubmed: 22566779
Indian J Pathol Microbiol. 2010 Oct-Dec;53(4):681-5
pubmed: 21045392
Breast Care (Basel). 2008;3(1):4-5
pubmed: 20824012
Ecancermedicalscience. 2015 Jun 25;9:548
pubmed: 26180547
Lancet Oncol. 2010 Feb;11(2):165-73
pubmed: 20005175
PLoS One. 2015 Feb 27;10(2):e0118989
pubmed: 25723522
J Cancer Res Clin Oncol. 2007 Jan;133(1):13-21
pubmed: 16865407
Open Virol J. 2017 Mar 31;11:15-27
pubmed: 28567162
Int J Equity Health. 2017 Mar 31;16(1):56
pubmed: 28359262
Asian Pac J Cancer Prev. 2014;15(9):4061-5
pubmed: 24935597
J Natl Cancer Inst. 2016 Jan 28;108(6):djv403
pubmed: 26823521
Future Oncol. 2012 Jun;8(6):697-702
pubmed: 22764767
Biochim Biophys Acta. 1996 Oct 9;1288(2):F55-78
pubmed: 8876633
Front Oncol. 2018 Jun 08;8:209
pubmed: 29938198
PLoS Comput Biol. 2015 Mar 13;11(3):e1004113
pubmed: 25769112
Lancet. 2007 Sep 8;370(9590):890-907
pubmed: 17826171
Infect Genet Evol. 2020 Oct;84:104368
pubmed: 32470632
Med Hypotheses. 1997 Jun;48(6):491-7
pubmed: 9247892
Curr Oncol Rep. 2002 Mar;4(2):175-83
pubmed: 11822990
J Med Virol. 2012 Dec;84(12):1920-7
pubmed: 23080497
Asian Pac J Cancer Prev. 2020 Jan 01;21(1):133-137
pubmed: 31983175
J Virol. 2003 Jan;77(2):1551-63
pubmed: 12502868
PLoS One. 2015 Aug 21;10(8):e0136050
pubmed: 26295705
J Med Virol. 2018 Mar;90(3):564-570
pubmed: 28975630
BMJ. 2000 Sep 9;321(7261):624-8
pubmed: 10977847
BMC Cancer. 2011 Jan 20;11:27
pubmed: 21247504
Br J Cancer. 2004 Jun 1;90(11):2149-52
pubmed: 15150559
Lancet. 2015 Mar 14;385(9972):977-1010
pubmed: 25467588
Lancet Oncol. 2005 Apr;6(4):204
pubmed: 15830458
Asian Pac J Cancer Prev. 2012;13(1):367-70
pubmed: 22502702
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
pubmed: 15761078
Br J Cancer. 2016 Aug 23;115(5):588-91
pubmed: 27253173
Infect Agent Cancer. 2017 Oct 16;12:55
pubmed: 29075317
Virology. 2009 Feb 20;384(2):260-5
pubmed: 19135222
Sci Rep. 2017 Feb 27;7:43591
pubmed: 28240743
Breast Cancer Res Treat. 1992;21(2):95-100
pubmed: 1320958
Iran Red Crescent Med J. 2012 Dec;14(12):798-804
pubmed: 23483369
J Int Med Res. 2011;39(5):1636-44
pubmed: 22117964
Br J Cancer. 2009 Oct 20;101(8):1345-50
pubmed: 19724278
Iran J Pathol. 2015 Summer;10(3):192-8
pubmed: 26351484
Clinics (Sao Paulo). 2018 Oct 18;73:e465
pubmed: 30365827
CA Cancer J Clin. 2019 May;69(3):184-210
pubmed: 30875085
BMJ Open. 2016 Aug 26;6(8):e011371
pubmed: 27566633
Papillomavirus Res. 2018 Jun;5:150-155
pubmed: 29660489
Asian Pac J Cancer Prev. 2014;15(6):2461-4
pubmed: 24761847
Infect Agent Cancer. 2019 Nov 29;14:42
pubmed: 31798679
Br J Cancer. 2008 Aug 5;99(3):404-7
pubmed: 18648363
Breast Cancer Res Treat. 2004 Mar;84(2):131-7
pubmed: 14999143
Clin Biochem. 2006 Jul;39(7):727-31
pubmed: 16780823